Faberco Life Sciences, Inc, in partnership with Serum
Institute of India (SII) is making CovovaxTM, the COVID-19
vaccine developed by Novavax available in the Philippines.
It has come to our attention a claim made by a local
government official that “Mikey Arroyo received the Covovax
vaccine.” The company assures the public that this claim is
entirely false and inaccurate and the same has been denied by
Representative Arroyo himself.
Faberco has not imported or brought into the country
even a single vial of the Covovax vaccine.
Faberco Life Sciences, Inc, abides by all the rules and
regulations with regards to obtaining an Emergency Use
Authorization (EUA). We assure the public that the importation
by our company of CovovaxTM vaccine will be in strict
compliance with the laws of the Government of the Philippines.
.